- vaccine: BNT162b2
  dosage: 1.0
  infection: ''
  num_ref_name: 26
  num_fold: 3957
  S: 3139
  I: 727
  R: 91
  median_fold: 2.0
  percent: 4.1
  priority: 1
- vaccine: BNT162b2
  dosage: 1.0
  infection: infected
  num_ref_name: 23
  num_fold: 1173
  S: 891
  I: 246
  R: 36
  median_fold: 2.6
  percent: 1.2
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 177
  num_fold: 20281
  S: 14484
  I: 4656
  R: 1141
  median_fold: 2.7
  percent: 21.0
  priority: 1
- vaccine: BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 44
  num_fold: 2855
  S: 1817
  I: 932
  R: 106
  median_fold: 3.2
  percent: 2.9
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 68
  num_fold: 5684
  S: 3425
  I: 1988
  R: 271
  median_fold: 4.0
  percent: 5.8
  priority: 1
- vaccine: BNT162b2
  dosage: 3.0
  infection: infected
  num_ref_name: 11
  num_fold: 652
  S: 521
  I: 110
  R: 21
  median_fold: 2.0
  percent: 0.67
  priority: 1
- vaccine: mRNA-1273
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 155
  S: 131
  I: 24
  R: 0
  median_fold: 1.5
  percent: 0.16
  priority: 2
- vaccine: mRNA-1273
  dosage: 1.0
  infection: infected
  num_ref_name: 2
  num_fold: 14
  S: 7
  I: 4
  R: 3
  median_fold: 5.3
  percent: 0.014
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 65
  num_fold: 8915
  S: 6080
  I: 2401
  R: 434
  median_fold: 3.9
  percent: 9.2
  priority: 2
- vaccine: mRNA-1273
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 354
  S: 250
  I: 84
  R: 20
  median_fold: 3.1
  percent: 0.36
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 18
  num_fold: 4053
  S: 2920
  I: 1091
  R: 42
  median_fold: 4.3
  percent: 4.2
  priority: 2
- vaccine: mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 305
  S: 207
  I: 97
  R: 1
  median_fold: 2.3
  percent: 0.31
  priority: 2
- vaccine: AZD1222
  dosage: 1.0
  infection: ''
  num_ref_name: 8
  num_fold: 858
  S: 432
  I: 173
  R: 253
  median_fold: 4.8
  percent: 0.88
  priority: 3
- vaccine: AZD1222
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 43
  S: 41
  I: 2
  R: 0
  median_fold: 2.1
  percent: 0.044
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: ''
  num_ref_name: 38
  num_fold: 2404
  S: 1514
  I: 643
  R: 247
  median_fold: 3.8
  percent: 2.5
  priority: 3
- vaccine: AZD1222
  dosage: 2.0
  infection: infected
  num_ref_name: 12
  num_fold: 528
  S: 468
  I: 37
  R: 23
  median_fold: 1.5
  percent: 0.54
  priority: 3
- vaccine: AZD1222
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 471
  S: 225
  I: 246
  R: 0
  median_fold: 5.8
  percent: 0.48
  priority: 3
- vaccine: BBIBP-CorV
  dosage: 2.0
  infection: ''
  num_ref_name: 10
  num_fold: 2518
  S: 1384
  I: 799
  R: 335
  median_fold: 4.1
  percent: 2.6
  priority: 5
- vaccine: BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 609
  S: 170
  I: 438
  R: 1
  median_fold: 9.4
  percent: 0.63
  priority: 5
- vaccine: BBV152
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 477
  S: 449
  I: 7
  R: 21
  median_fold: 1.4
  percent: 0.49
  priority: 6
- vaccine: BBV152
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 170
  S: 151
  I: 0
  R: 19
  median_fold: 2.4
  percent: 0.17
  priority: 6
- vaccine: CoronaVac
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 134
  S: 134
  I: 0
  R: 0
  median_fold: 4.3
  percent: 0.14
  priority: 7
- vaccine: CoronaVac
  dosage: 1.0
  infection: infected
  num_ref_name: 3
  num_fold: 390
  S: 242
  I: 148
  R: 0
  median_fold: 3.3
  percent: 0.4
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 18
  num_fold: 1990
  S: 1420
  I: 550
  R: 20
  median_fold: 2.6
  percent: 2.0
  priority: 7
- vaccine: CoronaVac
  dosage: 2.0
  infection: infected
  num_ref_name: 7
  num_fold: 250
  S: 136
  I: 74
  R: 40
  median_fold: 4.7
  percent: 0.26
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 11
  num_fold: 1426
  S: 572
  I: 854
  R: 0
  median_fold: 5.2
  percent: 1.5
  priority: 7
- vaccine: CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 3
  num_fold: 938
  S: 559
  I: 379
  R: 0
  median_fold: 3.6
  percent: 0.96
  priority: 7
- vaccine: NVX-CoV2373
  dosage: 2.0
  infection: ''
  num_ref_name: 4
  num_fold: 253
  S: 110
  I: 72
  R: 71
  median_fold: 7.3
  percent: 0.26
  priority: 8
- vaccine: ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 6
  num_fold: 611
  S: 172
  I: 399
  R: 40
  median_fold: 8.1
  percent: 0.63
  priority: 10
- vaccine: Sputnik V
  dosage: 2.0
  infection: ''
  num_ref_name: 8
  num_fold: 568
  S: 396
  I: 130
  R: 42
  median_fold: 4.0
  percent: 0.58
  priority: 11
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: ''
  num_ref_name: 21
  num_fold: 1483
  S: 1072
  I: 343
  R: 68
  median_fold: 2.9
  percent: 1.5
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 1.0
  infection: infected
  num_ref_name: 7
  num_fold: 180
  S: 130
  I: 44
  R: 6
  median_fold: 2.6
  percent: 0.18
  priority: 12
- vaccine: Ad26.COV2.S
  dosage: 2.0
  infection: ''
  num_ref_name: 7
  num_fold: 502
  S: 289
  I: 197
  R: 16
  median_fold: 4.6
  percent: 0.52
  priority: 12
- vaccine: KCONVAC
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 251
  S: 241
  I: 10
  R: 0
  median_fold: 1.2
  percent: 0.26
  priority: 21
- vaccine: Convidecia
  dosage: 1.0
  infection: ''
  num_ref_name: 2
  num_fold: 215
  S: 215
  I: 0
  R: 0
  median_fold: 1.4
  percent: 0.22
  priority: 22
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 317
  S: 76
  I: 238
  R: 3
  median_fold: 7.7
  percent: 0.33
  priority: 29
- vaccine: BNT162b2 + mRNA-1273
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 149
  S: 124
  I: 17
  R: 8
  median_fold: 1.4
  percent: 0.15
  priority: 29
- vaccine: mRNA-1273 + mRNA-1273.211
  dosage: 3.0
  infection: ''
  num_ref_name: 3
  num_fold: 4882
  S: 4850
  I: 32
  R: 0
  median_fold: 2.3
  percent: 5.0
  priority: 32
- vaccine: AZD1222 + Sputnik V
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 76
  S: 0
  I: 76
  R: 0
  median_fold: 9.5
  percent: 0.078
  priority: 35
- vaccine: CoronaVac or BBIBP-CorV
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 588
  S: 541
  I: 47
  R: 0
  median_fold: 4.2
  percent: 0.6
  priority: 36
- vaccine: BBIBP-CorV + ZF2001
  dosage: 3.0
  infection: ''
  num_ref_name: 4
  num_fold: 252
  S: 52
  I: 182
  R: 18
  median_fold: 7.8
  percent: 0.26
  priority: 37
- vaccine: Ad26.COV2.S + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 270
  S: 135
  I: 135
  R: 0
  median_fold: 5.4
  percent: 0.28
  priority: 38
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 9
  num_fold: 649
  S: 372
  I: 271
  R: 6
  median_fold: 4.7
  percent: 0.67
  priority: 39
- vaccine: BNT162b2 + CoronaVac
  dosage: 3.0
  infection: infected
  num_ref_name: 2
  num_fold: 92
  S: 68
  I: 24
  R: 0
  median_fold: 2.0
  percent: 0.094
  priority: 39
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 225
  S: 98
  I: 107
  R: 20
  median_fold: 7.5
  percent: 0.23
  priority: 41
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 6
  S: 6
  I: 0
  R: 0
  median_fold: 0.65
  percent: 0.0062
  priority: 41
- vaccine: Ad26.COV2.S + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 5
  num_fold: 580
  S: 425
  I: 155
  R: 0
  median_fold: 2.6
  percent: 0.6
  priority: 41
- vaccine: AZD1222 + CoronaVac
  dosage: 2.0
  infection: ''
  num_ref_name: 2
  num_fold: 209
  S: 120
  I: 29
  R: 60
  median_fold: 3.3
  percent: 0.21
  priority: 42
- vaccine: AZD1222 + BNT162b2 + CoronaVac
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 89
  S: 89
  I: 0
  R: 0
  median_fold: 2.6
  percent: 0.091
  priority: 43
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: ''
  num_ref_name: 11
  num_fold: 805
  S: 393
  I: 233
  R: 179
  median_fold: 5.2
  percent: 0.83
  priority: 46
- vaccine: AZD1222 + BNT162b2
  dosage: 2.0
  infection: infected
  num_ref_name: 2
  num_fold: 12
  S: 6
  I: 5
  R: 1
  median_fold: 4.9
  percent: 0.012
  priority: 46
- vaccine: AZD1222 + BNT162b2
  dosage: 3.0
  infection: ''
  num_ref_name: 7
  num_fold: 555
  S: 346
  I: 209
  R: 0
  median_fold: 3.5
  percent: 0.57
  priority: 46
- vaccine: AZD1222 + mRNA-1273
  dosage: 2.0
  infection: ''
  num_ref_name: 3
  num_fold: 177
  S: 166
  I: 11
  R: 0
  median_fold: 2.5
  percent: 0.18
  priority: 47
- vaccine: AZD1222 + mRNA-1273
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 680
  S: 560
  I: 120
  R: 0
  median_fold: 1.8
  percent: 0.7
  priority: 47
- vaccine: AZD1222 + mRNA
  dosage: 3.0
  infection: ''
  num_ref_name: 2
  num_fold: 60
  S: 0
  I: 52
  R: 8
  median_fold: 9.4
  percent: 0.062
  priority: 52
- vaccine: Unknown vaccine
  dosage: 2.0
  infection: infected
  num_ref_name: 8
  num_fold: 814
  S: 639
  I: 114
  R: 61
  median_fold: 2.2
  percent: 0.84
  priority: 1000
- vaccine: Unknown vaccine
  dosage: 3.0
  infection: infected
  num_ref_name: 4
  num_fold: 358
  S: 271
  I: 79
  R: 8
  median_fold: 2.8
  percent: 0.37
  priority: 1000
